Cooley Continues its Capital Markets Leadership, Advising on a Record 100 Public Offerings in 2014
- #1 Law Firm Advising Issuers on IPOs
- #1 Law Firm for Technology and Life Sciences IPOs
- #1 Law Firm for Venture-Backed Company IPOs
Palo Alto – February 9, 2015 – For the second consecutive year, Cooley had a record breaking year handling capital markets transactions. In 2014, the firm advised on 100 completed equity offerings, including 50 initial public offerings. Cooley advised more issuers on IPOs than any other firm in the US.
According to IPO Vital Signs, Cooley was the number one firm handling technology and life sciences IPOs in 2013 and 2014, as well as venture-backed company IPOs across all industries. The firm advised on 27% of all venture-backed technology IPOs and 43% of all venture-backed life sciences IPOs in 2014.
"It was a tremendous year for companies going to the capital markets, particularly in the technology and life sciences sectors," said Fred Muto, chair of Cooley's business department. "Cooley remains one of the few true go-to firms for both issuers and investment banks. We have already seen a great deal of activity in 2015, and expect the pipeline to remain robust."
Cooley's capital markets lawyers advise issuers, investment banks and investors in equity and debt transactions that raise capital through the public and private capital markets. For a dynamic summary of Cooley's 2014 capital markets successes, please view the firm's capital markets 2014 IPO infographic.
About Cooley LLP
Cooley's lawyers solve legal issues for entrepreneurs, investors, financial institutions and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, often where innovation meets the law.
Cooley has 850 lawyers across 12 offices in the United States, China and Europe.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.